Clinica - Swedish objection letter highly critical of medtech quality system standard: details

Clinica Scrip Scrip Regulatory Affairs Scrip Clinical Research Animal Pharm

Advanced Search

Clinica

Swedish objection letter highly critical of medtech quality system standard: details

18 February 2011

Amanda Maxwell

Please Login to read the full article.

Not a subscriber ? Request a FREE Trial Subscribe to Clinica

RELATED CONTENT

NEWS

Clinica News

Australian panel recommends transparency overhaul at TGA
GAO finds gaps in the US FDA medical device recall procedures
US FDA analysis blames poor quality 510(k) submissions for delays in reviews
Gyros enlists GE to distribute immunoassay to Japan's biopharma market

Other Informa News

Comparative efficacy should have a "formal role in drug licensing"
Australian panel recommends transparency overhaul at TGA

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Market Sector

Business

Policy & Regulation

Regions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm